 |
 |

The New Definition of Myocardial Infarction
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
In reply. We would like to thank Drs Guerra and Szapary for highlighting an important issue with regard to the use of statins in the treatment of patients with acute coronary syndrome, and we appreciate the opportunity to clarify our data. While we noted a significantly lower 6-month mortality among patients diagnosed with acute myocardial infarction using the prior World Health Organization criteria (group A) compared with those diagnosed using the new European Society of Cardiology and American College of Cardiology criteria (group B), no difference in 6-month outcomes was observed after adjusting for age, sex, and patient characteristics. We have concluded that more comorbid conditions in group B may explain this observed mortality difference and that a more aggressive treatment approach may lead to improved outcomes. With respect to statins, their use was similar between patients in groups A and B, both at the time of admission (27% vs . . . [Full Text of this Article]
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLES
The New Definition of Myocardial Infarction
Carmen E. Guerra and Philippe O. Szapary
Arch Intern Med. 2003;163(2):245.
EXTRACT
| FULL TEXT
Effects of Atorvastatin on Early Recurrent Ischemic Events in Acute Coronary Syndromes: The MIRACL Study: A Randomized Controlled Trial
Gregory G. Schwartz, Anders G. Olsson, Michael D. Ezekowitz, Peter Ganz, Michael F. Oliver, David Waters, Andreas Zeiher, Bernard R. Chaitman, Sally Leslie, Theresa Stern, and for the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering Study Investigators
JAMA. 2001;285(13):1711-1718.
ABSTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Diagnosis of Lower-Extremity Deep Vein Thrombosis in Outpatients
Riddle and Wells
ptjournal 2004;84:729-735.
FULL TEXT
|